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ReportInvolvement of the Ubiquitin-
Proteasome System in the Early
Stages of Wallerian Degeneration
represent an additional and complementary therapeutic
avenue for these diseases.
The simplest model of axon degeneration known to
date is the self-destructive process observed at the dis-
tal portion of a transected axon upon injury, termed
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Stanford, California 94305 undergoing Wallerian degeneration do not seem to pos-
sess detectable activation of the caspase family cys-
teine proteases (Finn et al., 2000), the molecular hall-
marks of apoptosis activation, suggesting that Wallerian
Summary
degeneration and apoptosis may represent two distinct
self-destruct programs.
Local axon degeneration is a common pathological
Because most neuronal proteins are synthesized in
feature of many neurodegenerative diseases and pe-
the soma and carried to the axon by specialized axonal
ripheral neuropathies. While it is believed to operate
transport systems, degeneration of the transected ax-
with an apoptosis-independent molecular program,
ons has long been thought to result from starvation for
the underlying molecular mechanisms are largely un-
necessary proteins and other materials. However, the
known. In this study, we used the degeneration of
recent discovery of a spontaneously occurring mutant
transected axons, termed “Wallerian degeneration,”
mouse strain, C57BL/Wlds, whose axons survived for as
as a model to examine the possible involvement of
long as weeks after transection (Lunn et al., 1989; Glass
the ubiquitin proteasome system (UPS). Inhibiting UPS
et al., 1993), suggests that Wallerian degeneration in-
activity by both pharmacological and genetic means
volves an active and regulated autodestruction pro-
profoundly delays axon degeneration both in vitro and
gram. The ubiquitin-proteasome system (UPS) has been
in vivo. In addition, we found that the fragmentation
implicated as a common mechanism for selective pro-
of microtubules is the earliest detectable change
tein degradation in a variety of biological processes,
in axons undergoing Wallerian degeneration, which
such as axonal pathfinding (Campbell and Holt, 2001)
among other degenerative events, can be delayed by
and synapse formation (DiAntonio et al., 2001). In addi-
proteasome inhibitors. Interestingly, similar to tran-
tion, an intragenic deletion in the gene encoding ubiqui-
sected axons, degeneration of axons from nerve
tin carboxy-terminal hydrolase has recently been found
growth factor (NGF)-deprived sympathetic neurons
to account for the axon degeneration phenotype of the
could also be suppressed by proteasome inhibitors.
gracile axonal dystrophy (gad) mouse (Saigoh et al.,
Our findings suggest a possibility that inhibiting UPS
1999). Also, the slow Wallerian degeneration phenotype
activity may serve to retard axon degeneration in
in the Wlds mice has been attributed to the overexpres-
pathological conditions.
sion of a fusion protein that consists of the amino-termi-
nal 70 amino acids of UFD2, an E4 protein involved in
polyubiquitination, and the nicotinamide mononucleo-Introduction
tide adenylyltransferase (Nmnat) (Mack et al., 2001), im-
plying a potential involvement of UPS in Wallerian de-Axon degeneration occurs frequently in many types of
chronic neurodegenerative diseases and in injuries to generation. However, the region of UFD2 in the fusion
protein of Wlds mice is absent in the functionally con-axons caused by toxic, ischemic, or traumatic insults
(Raff et al., 2002; Coleman and Perry, 2002). It may lead served homolog of UFD2 in yeast (Koegl et al., 1999),
thus leaving it unclear whether there is contribution fromto separation of the neuron from its targets, resulting in
loss of neuronal function. In the past, much effort has UPS to the phenotype of Wlds mice. In this study, we
provide both pharmacological and genetic evidence thatbeen focused on understanding the nature of neuronal
cell death in these diseases (Yuan and Yankner, 2000). UPS inhibition can profoundly delay Wallerian degenera-
tion, possibly by stabilizing microtubule skeletons at theHowever, strategies designed to prevent neuronal cell
death have resulted in only limited success in preventing early stages of Wallerian degeneration.
or delaying neurodegeneration. One possibility is that
neuronal cell death occurs too late in these diseases, Results
so that it may not be an efficient target for therapy. Thus,
interfering with the process of axon degeneration may Inhibiting the UPS Delays Wallerian Degeneration
Wallerian degeneration in most transected mammalian
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Figure 2. Characterization of Axonal Markers
during Wallerian Degeneration
Cultured SCGs were fixed at indicated post-
axotomy time points and either labeled with
DiI to show the plasma membrane structures
(A) or immunostained with antibodies against
NF160 (B) or -tubulin (C) to show the struc-
tures of microtubules and neurofilaments.
Scale bar, 10 m.
cells, alternations in the blood-tissue barriers, and re- severed axons first appear normal for 6–10 hr, de-
pending upon the duration of culturing prior to axotomy.sponses of macrophages (reviewed by Griffin et al.,
1995). To study the underlying mechanisms involved For SCGs that have been cultured for 5 days, the severed
axons begin to develop such signs of early degenerationin the axon degeneration process, we have used the
degeneration of transected axons from cultured primary as focal swelling and beading approximately 8 hr after
the axons have been separated from their cell bodiesneurons as models (George et al., 1995; Wang et al.,
2001a). In cultured sympathetic superior ganglia (SCGs) (Figures 1A and 1B). In most cases, the axons com-
pletely degenerated and detached after 12–16 hr post-derived from postnatal day 3 rats, soma-deprived axons
undergo a typical degenerative process (Figure 1A). The axotomy (Figure 1A). Similar degenerative processes
Figure 1. Inhibiting UPS Delays Wallerian Degeneration
(A) Wallerian degeneration is delayed by MG132, EGTA, and ALLN. MG132 (20 M), EGTA (2 mM), or ALLN (50 M) was added to 5 day
cultured SCGs prior to axotomy, and representative phase images were taken at the indicated time points postaxotomy. Scale bar, 10 m.
(B) Quantification of axon degeneration results. Statistical analysis was done by two-way ANOVA using Graphpad Prism. p  0.0001 for
MG132 versus control, lactacystin (20 M) versus control, EGTA versus control, and ALLN versus control.
(C) Quantification showing the protective effects of MG132 pretreatment but not posttreatment from axon degeneration at 8 hr postaxotomy.
MG132 (20 M) was added to the cultures 0, 1, or 3 hr prior to or after axotomy. Only the groups of pretreatment for 3 hr or 1 hr are significantly
different (**p  0.001; *p  0.05, Student’s t test) from control.
(D) Immunostaining of sympathetic axons with control IgG or rabbit antibodies against proteasome 20S subunit C2. Scale bar, 10 m.
(E) Quantification of axon degeneration results. Statistical analysis was done by two-way ANOVA using Graphpad Prism. HSV-UBP2 versus
control HSV, p  0.0001.
(F) Western blotting showing the expression of UBP2 in infected SCGs. The same blot was reblotted with anti--tubulin to show an equal
amount of cellular proteins loaded in both lanes. Scale bar, 8 m.
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Figure 3. Proteasome Inhibitors Protect Microtubule Destabilization during Wallerian Degeneration
(A) Cultured SCGs were pretreated with or without MG132 (20 M), axotomized, and fixed at indicated postaxotomy time points, and
immunostained with an anti--tubulin antibody to show the structures of microtubules.
(B) Quantification of axons with microtubule fragmentation staining in different conditions (control, MG132 [20 M], EGTA [2 mM], or ALLN
[50 M]). Statistical analysis was done by two-way ANOVA using Graphpad Prism. p  0.0001 for MG132 versus control and EGTA versus
control.
(C) MG132 prevents axotomy-elicited microtubule depolymerization. Statistical analysis from five experiments was done by two-way ANOVA
using Graphpad Prism. In the absence of MG132, the groups of 4 and 8 hr posttransected axons were significantly different from the 0 hr
group (p  0.0001). MG132-treated groups (except for 0 hr) were significantly different from control ones (p  0.0001).
(D) Neurofilament degeneration during Wallerian degeneration is protected by MG132 (20 M). Scale bar, 10 m.
(E) Western blotting showing the effects of MG132 (20 M), EGTA (2 mM), or ALLN (50 M) on protein degradation of neurofilament components
and -tubulin in transected axons.
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cluded in SCG cultures, these proteasome inhibitors did
not significantly alter the gross morphology of the uncut
axon but profoundly delayed the Wallerian degeneration
process (Figures 1A and 1B). Compared to untreated
transected axons that began developing early signs of
degeneration 8 hr postaxotomy, those treated with both
MG132 and lactacystin did not show degeneration until
16 hr postaxotomy (Figures 1A and 1B). Twenty-four
hours postaxotomy, when most of the axon debris has
detached from the culture surface in control cultures,
proteasome inhibitor-treated explants still retained
many axons with some degeneration signs (Figure 1A).
Because of the difficulty in quantifying axons with signs
of later stages of degeneration, such as debris and de-
tachment, we have quantified only the results of axons
with early signs of degeneration in Figure 1B to illustrate
the effects of proteasome inhibitors on delaying the on-
set of degeneration. This effect appeared to be specific
for proteasome inhibitors, as the inclusion of a caspase
inhibitor, Z-VAD-fmk, or a serine protease inhibitor,
pepstatin A, did not result in any detectable protective
effect (data not shown). Interestingly, such a protective
effect only occurred when these proteasome inhibitorsFigure 4. Inhibiting the UPS Delays Wallerian Degeneration of
were added to the cultures prior to axotomy (Figure 1C).Crushed Optic Nerves In Vivo
As it is known that these inhibitors are able to quickly(A) Immunostaining micrographs of the distal portion of transected
optic nerves with neuron-specific anti--tubulin and anti-NF160 an- execute their inhibitory effects upon addition to the cul-
tibodies. Scale bar, 8 m. tures (Campbell and Holt, 2001), these results suggest a
(B) Quantification of the fiber structures by immunostaining on optic role of UPS in the early stages of Wallerian degeneration.
nerve sections from control, 3, 7, or 14 days without MG132 and To provide additional evidence for the involvement
3 days with MG132. Statistical analysis was done by two-way AN-
of the UPS in Wallerian degeneration, we constructedOVA using Graphpad Prism. For both -tubulin and NF160 staining,
recombinant herpes simplex viruses (HSV) to express inthe groups of 3, 7, and 14 days are significantly different from the
control groups (all p  0.001). For all of the time points except for cultured sympathetic neurons a yeast ubiquitin protease
control groups, the groups of -tubulin staining are significantly (UBP2), which has been shown to reverse substrate
different from those of NF160 staining (all p  0.001). There are ubiquitination across different species (Baker et al.,
significant differences between 3 days with or without MG132 for 1992; DiAntonio et al., 2001; Watts et al., 2003). We found
both NF160 and -tubulin staining (paired Student’s t test, p 
that sympathetic neurons infected with HSV expressing0.001).
UBP2, but not control HSV, showed a significantly
slower rate of degeneration (Figures 1E and 1F). How-
ever, the protective effects of UBP2 overexpressionwere also observed in other types of cultured neurons,
were less robust than those of the proteasome inhibi-such as chicken dorsal root ganglion neurons and retinal
tors, presumably due to the low expression levels ofganglion cells (data not shown).
UBP2 (Figure 1F). Thus, the proteasome inhibitors wereWe next attempted to examine whether UPS is in-
used for the rest of the study.volved in axotomy-triggered Wallerian degeneration by
Consistent with previous studies (Finn et al., 2000),using specific pharmacological inhibitors. It is known
addition of ALLN (50M), an inhibitor of calcium-depen-that for UPS to degrade a specific substrate protein, the
dent proteases calpains, did not affect the developmentsequential action of three enzymes, including a ubiquitin
of the axonal beading appearance but slightly delayedactivating enzyme (E1), a ubiquitin conjugating enzyme
the disintegration of transected axons into debris (Fig-(E2), and a ubiquitin ligase (E3), are required to cova-
ures 1A and 1B). These results together suggest thatlently link ubiquitin to the substrate. Polyubiquitinated
UPS and calpains may act on different stages of Wal-proteins are then targeted for degradation by the 26S
lerian degeneration. Interestingly, application of the cal-proteasome, which is composed of two 19S proteasome
cium chelator EGTA (2 mM) resulted in a much strongerregulatory particles and a 20S core. Substrate ubiquiti-
protective effect on Wallerian degeneration than ALLNnation may also be reversed by ubiquitin proteases (re-
(Figure 1A) and other calpain inhibitors (data not shown).viewed by Weissman, 2001). Consistent with previous
This observation suggests that the calpains might not beevidence for the existence and functioning of the UPS
the only calcium-dependent event involved in Wallerianin axons (Campbell and Holt, 2001), components of UPS
degeneration. The UPS is unlikely to be activated bymachinery, such as subunit C2 of the proteasome 20S
elevated intracellular calcium levels, because the axon(Figure 1D), were found in both intact and transected
degeneration elicited by calcium ionophore A23187 oraxons from sympathetic neurons.
ionomycin were blocked by EGTA but not MG132 (dataTo perturb UPS activity, we used two mechanistically
not shown). However, we cannot rule out the possibilitydifferent proteasome inhibitors: MG132, a peptide-
that there is a calcium-dependent step in the participa-based reversible proteasome inhibitor; and lactacystin,
a synthetic irreversible proteasome inhibitor. When in- tion of the UPS in Wallerian degeneration.
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Microtubule Destabilization at the Initiation Stage inhibitors, and EGTA affect neurofilaments and microtu-
bules in transected axons. Both MG132 and EGTA pro-of Wallerian Degeneration In Vitro
We next examined which cellular events might correlate foundly retarded the degeneration of all examined sub-
cellular markers, including both the destabilization ofwith the involvement of the UPS and calpains in Wal-
lerian degeneration. To this end, we monitored the integ- microtubules (Figures 3A–3C) and the cleavage of neu-
rofilaments (Figures 3D and 3E, data not shown). How-rity of different subcellular organelles in the transected
axons by both immunocytochemistry and membrane ever, ALLN only delayed neurofilament degradation (Fig-
ure 3E), not the fragmentation of microtubules (Figurelabeling (Figure 2). Plasma membrane staining with both
a lipophilic dye DiI (Figure 2A) and antibodies against 3B). While confirming a critical involvement of calpains
in the cleavage of neurofilaments (Schlaepfer et al.,an axonal surface molecule p75 (data not shown), as
well as cytoplasmic staining with an antibody against 1984; Finn et al., 2000), these results also suggest that
both calcium-dependent events and the UPS are criticalPGP9.5, an abundant axonal cytoplasmic protein (George
et al., 1995; Finn et al., 2000, data not shown), revealed for the disassembly of microtubules and perhaps other
early events of Wallerian degeneration.characteristic morphological changes of Wallerian de-
generation as depicted in Figure 1A, with the onset of
swelling and beading followed by fragmentation and MG132 Slows Down Wallerian Degeneration
detachment of axonal debris. Likewise, immunostaining of Transected Optic Nerve In Vivo
with an anti-neurofilament NF160 (2H3) antibody To assess whether these observations from in vitro cul-
showed a similar time course of degeneration (Figure ture experiments hold true in vivo, we first performed
2B), consistent with previous observations that neurofil- immunostaining experiments to examine the alterations
aments are broken down during Wallerian degeneration of microtubules and neurofilaments in transected optic
(Schlaepfer et al., 1984; Finn et al., 2000). At the protein nerves (Figure 4). In uncut optic nerves, antibodies
level, we observed a corresponding cleavage of the neu- against both neurofilament and tubulin components re-
rofilament subunits neurofilament 160 (NF-160) and neu- vealed numerous fiber structures of the axon cytoskele-
rofilament 68 (NF68) as detected by Western blotting ton (Figures 4A and 4B). In optic nerves 3 days after
(Figure 3E). Apart from these axonal markers, however, axotomy, when an anti-NF160 antibody still detected
the earliest detectable change appears to occur in the many linear neurofilaments fibers, an anti--tubulin anti-
microtubules of transected axons. Immunostaining with body revealed largely spheroid bodies, reminiscent of
antibodies against both -tubulin (data not shown) and the microtubule changes observed in vitro 16 hr post-
-tubulin (Figures 2C, 3A, and 3B) revealed fragmented axotomy (Figure 2). Similar staining patterns were ob-
microtubule structures in approximately 60% of the tran- served in transected optic nerves 7 or 14 days postaxo-
sected axons 4 hr after axotomy (Figures 2C and 3B), tomy (Figure 4B). As previous studies implicated
when other subcellular structures were still largely in- neurofilament degradation as an early marker of Wal-
tact, as suggested by both phase contrast image analy- lerian degeneration (Glass et al., 2002), our results sug-
sis (Figure 1A) and immunostaining (Figures 2A and 2B). gest that destabilization of microtubules might occur
After 12 hr postaxotomy, the stained signals of frag- prior to that of neurofilaments following axotomy.
mented microtubule structures weakened gradually and To examine whether proteasome inhibitors would re-
were replaced by many spheroid bodies in severed ax- tard Wallerian degeneration in vivo, we applied gelfoams
ons. By 16 hr after axotomy, almost all of the detected presoaked with vehicle (PBS) or MG132 to the lesion
signals were spheroid bodies along the tracts of original sites and examined the transected optic nerves 3 days
axons. Surprisingly, even 16 hr after axotomy, when postaxotomy by immunostaining. As expected, MG132
the majority of the axonal NF160 and NF68 had been significantly slowed down the breakdown of microtu-
degraded, most of the tubulin proteins still remained bules and neurofilaments (Figures 4A and 4B) as well as
intact, and the protein level remained stable according axolemma as detected by anti-PGP9.5 antibody staining
to Western blotting (Figure 3E). (data not shown) in transected optic nerves. However,
To provide additional biochemical evidence for such since the effect of drugs presoaked in gelfoams is likely
an axotomy-elicited microtubule destabilization in tran- to decrease over time, we could not determine the maxi-
sected axons at early stages of Wallerian degeneration, mum extent to which these proteasome inhibitors could
we separated monomeric/dimeric (soluble, S) and poly- slow down Wallerian degeneration in vivo. Nevertheless,
merized (pellet, P) tubulins from transected axons and these results together suggest that inhibiting UPS activ-
measured the depolymerization ratio (S/[SP]) at differ- ity is able to delay Wallerian degeneration both in vitro
ent time points. As shown in Figure 3C, microtubule and in vivo.
depolymerization in transected axons was significantly
increased as early as 4–8 hr postaxotomy. These results Proteasome Inhibitors also Delay Neurite
together suggest that the breakdown of neurofilaments Degeneration in NGF-Deprived Sympathetic Neurons
and microtubules might be mediated by different mech- In addition to transected axons, axons from neurons
anisms, with neurofilament proteins being cleaved and that have been deprived of their physiological trophic
microtubule polymers simply being disassembled. factors may also undergo a Wallerian-like degeneration
process (reviewed by Raff et al., 2002). If the distal part
of an axon of a cultured sympathetic neuron is locallyThe UPS and Calpains Mediate the Breakdown
of Axonal Cytoskeleton Components deprived of NGF, that part of the axon degenerates while
the rest of the cell and axon survives (Campenot, 1982).To explore the possible link between these cellular and
molecular changes during Wallerian degeneration, we Moreover, it has been shown that such NGF deprivation-
triggered axon degeneration is delayed in the sympa-next examined whether proteasome inhibitors, calpain
The UPS in Wallerian Degeneration
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Figure 5. Inhibiting the UPS Prevented Axon
Degeneration but Not Soma Death of NGF-
Deprived Sympathetic Neurons
Alter changing to the medium with NGF (con-
trol) or without NGF (NGF-dep.) in the pres-
ence or absence of MG132 (20 mM) or Z-VAD-
fmk (20 mM), SCGs were kept in culture for an
additional 36 hr prior to acquisition of phase
contrast images (phase) and fixation. The
fixed cultures were then stained with anti-
-tubulin antibodies to show the microtubule
structures and with Hoechst 33258 to show
fragmented nuclei. Scale bar, 8 m for phase
and anti--tubulin and 4 m for Hoechst
33258 micrographs.
thetic neurons from Wlds mice (Deckwerth and Johnson, Involvement of the UPS in the Early Stages
of Wallerian Degeneration1994). We thus decided to investigate whether UPS is
also involved in NGF deprivation-triggered axon degen- How is the UPS involved in Wallerian degeneration?
Axon degeneration is protected only by pretreatmenteration. Consistent with previous studies (for example,
Deckwerth and Johnson, 1994), 36 hr after NGF depriva- with the proteasome inhibitors, suggesting an involve-
ment of UPS at the early stage(s) of Wallerian degenera-tion, all of the cultured sympathetic neurons underwent
a typical apoptosis program, with death of cell bodies tion. This notion is further substantiated by the results
that UPS inhibitors are able to retard the developmentas detected by nuclei staining with Hoechst 33258 (a
few normally stained nuclei are glial cells) and degenera- of early signs of Wallerian degeneration. There are two
possible mechanisms that may account for the earlytion of axons as indicated by both morphological criteria
and immunostaining (Figure 5). The caspase inhibitor involvement of UPS in Wallerian degeneration. For one,
it can activate many E3 proteins to trigger a genericZ-VAD-fmk efficiently prevented both cell body death
and neurite degeneration (Figure 5). However, in the protein degradation program. Alternatively, it may acti-
vate a single or a subset of E3s that mediate the degra-presence of MG132, while these neuronal cell bodies
still showed clear apoptotic staining, the majority of the dation of key protein(s) that can then trigger a secondary
phase of the degenerative process. Our results favoraxons were still intact (Figure 5), suggesting that MG132
specifically delays axon degeneration but not the death the latter possibility, as microtubule fragmentation, a
specific and earliest detectable change during Wallerianof cell bodies. In addition, overexpression of the yeast
UBP2 protein by a recombinant HSV also showed a degeneration, is dependent on UPS. Although protea-
some inhibitors can also retard the degeneration of otherqualitatively similar but less profound protective effect
on the degeneration of axons and not the death of cell axonal structures, such as axolemma and neurofila-
ments, it is possible that these alterations are secondarybodies (data not shown). Thus, it is possible that the
molecular events underlying Wallerian degeneration to the disruption of microtubules in the transected ax-
ons. Consistent with this notion, we found that protea-may also participate in other pathological conditions
that have been thought to depend only on the apoptosis some inhibitors cannot protect the Wallerian-like neu-
rite degeneration elicited by microtubule destabilizingmachinery.
agents, such as colchicine and vincristine (data not
shown). It remains unclear whether microtubule destabi-Discussion
lization is the only immediate consequence upon the
activation of UPS in the transected axons during Wal-In this study, we have used both pharmacological and
lerian degeneration.genetic means to show that the UPS plays a critical role
in the early stages of Wallerian degeneration, possibly
by eliciting the destabilization of axon microtubules that Microtubule Destabilization
in Wallerian Degenerationin turn triggers a late phase of axon degeneration. We
also demonstrate that proteasome inhibitors are able to While microtubule destabilization is sufficient to induce
axon degeneration (Luduena et al., 1986; Wang et al.,delay neurite degeneration but not cell body apoptosis
in NGF-deprived sympathetic neurons, providing addi- 2001b), disruption of neurofilaments by the introduction
of anti-NF160 into Xenopus embryos did not affect thetional support that Wallerian degeneration operates via
an apoptosis-independent molecular mechanism. distribution of microtubules and other axon cytoskele-
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ton structures (Walker et al., 2001). Moreover, we found kinje neurons (Chen and Hillman, 1999) and in peripheral
nerves damaged by a wide variety of toxic, metabolic,that latrunculin B, an actin depolymerizing agent, failed
to induce axon degeneration in our assays (data not and infectious insults (Raff et al., 2002). In these cases,
axon degeneration begins distally and spreads towardshown). Thus, among the three major polymer compo-
nents of the axon cytoskeleton, microtubules may play the cell body. Although the underlying mechanisms for
these local axon degenerations remain largely unclear,a particularly important role in maintaining the integrity
of axons. existing evidence supports a potential mechanistic link
between such a dying-back process and Wallerian de-How are the axonal microtubules disrupted during
Wallerian degeneration? Our results indicate that al- generation. For instance, the dying-back degeneration
elicited by vincristine, a clinical anti-tumor drug with athough an increased portion of microtubules appear
fragmented and depolymerized, tubulin proteins per se common side effect of inducing axonal degeneration-
associated peripheral neuropathy (Schaumburg et al.,are not cleaved at least at the early stages of Wallerian
degeneration. Thus, the axonal tubulin proteins are not 1992), is protected in neurons from Wlds mice (Wang et
al., 2001b). Interestingly, a mutation in the Uch-I1 genelikely to be direct UPS substrates. It is known that the
stability of microtubules in the neurons is controlled by accounts for dying-back axon degeneration and the for-
mation of spheroid bodies in degenerating nerve termi-a balance between stabilizing factors, notably microtu-
bule associated proteins (MAPs; Garcia and Cleveland, nals in gad mice (Saigoh et al., 1999), pointing to the
importance of UPS in maintaining the integrity of axons.2001), and destabilizing factors, such as the Kin kinesin
KIF2 (Desai et al., 1999). It is conceivable that, upon It is known that the specificity of UPS-mediated proteol-
ysis is determined by specific E2/E3 and perhaps hy-axotomy, engagement of UPS may lead to microtubule
destabilization by degrading the stabilizing factors or drolases. Thus, a future challenge will be to identify
specific E2/E3 molecules involved in maintaining thethe inhibitory molecules of destabilizing factors. Al-
though our preliminary results suggest that the protein integrity of axons and mediating the degeneration of
axons.levels of two abundant MAPs (MAP1 and Tau) are stable
at early stages of Wallerian degeneration, future studies
are needed to examine whether other less abundant Experimental Procedures
MAPs or microtubule destabilization factors may be the
Explant Cultures, Axotomy, and NGF Deprivationtargets of UPS-mediated proteolysis. In addition, the
SCGs dissected from P3 rats were cultured for 5 days in 6-well platesfact that microtubule fragmentation is also protected by
precoated with poly-D-lysine and laminin in DMEM/F12 medium
EGTA but not by calpain inhibitors suggests that an supplemented with 10% fetal bovine serum, 2 mM glutamine, 100
unknown calcium-dependent event might cooperate ng/ml NGF, 10 M cytosine arabinoside, and antibiotics. For axo-
tomy, axons were cut through the axonal halo around each ganglionwith UPS to induce the destabilization of axon microtu-
with a microscalpel and the ganglion was removed, leaving thebules during Wallerian degeneration.
transected axons in the culture dish. To deprive the neuronal culture
of NGF, the medium was removed on day 5 in culture and substituted
The Physiological and Pathological Relevance with the same medium without NGF. To observe the effects of differ-
of the Mechanisms of Wallerian Degeneration ent pharmacological perturbations on axon degeneration, MG132
and lactacystin were added to the cultures 3 hr prior to axotomyThe realization that Wallerian degeneration is brought
or NGF deprivation. Other inhibitors, including ALLN, pepstatin A,about by an active program rather than a passive “wast-
V-ZAD-fmk, and EGTA, were added 1 hr prior to axotomy or NGFing-away” process suggests that such a molecular
deprivation. At indicated time points postaxotomy or after NGF dep-mechanism may also function in normal physiological
rivation, two representative phase micrographs were taken from
contexts. It is known that selective axon removal is an each explant. To quantify percentages of axons with degeneration
important means of fine-tuning or remodeling neuronal (with beading and/or fragmented appearance) from phase images,
at least 200 singly distinguishable axons were blindly scored fromconnectivity during development and in the adult
several randomly taken images of entire explants per condition from(O’Leary and Koester, 1993; Sanes and Lichtman, 1999).
duplicate explants per experiment and from three independent ex-Interestingly, a recent study examining the stereotyped
periments.pruning of  neurons of the Drosophila mushroom bod-
Immunocytochemistry was performed with the following antibod-
ies during metamorphosis demonstrated that such ies: monoclonal anti--tubulin (TUJ1) and anti-NF160 (2H3), poly-
pruning is mediated by local degeneration, which also clonal antibodies against p75 neurotrophin receptor (Covance).
To determine how much tubulin protein is in soluble (or depoly-requires the action of UPS (Watts et al., 2003). Strikingly,
merized) form, we followed a standard procedure (Jacob andin this pruning process, disruption of the microtubule
McQuarrie, 1996; Lund et al., 2002) to treat transected axons withcytoskeleton is also the earliest detectable change.
polymer stabilizing buffer (100 mM Pipes [pH 6.9], 5 mM EGTA, 5These observations strongly suggest that some types
mM MgCl2, 20% glycerol, 5% DMSO, 0.2% Triton X-100, proteaseof developmental axon pruning and Wallerian degenera- inhibitor cocktail, 12 M Taxol). After centrifugation (16,000  g (90
tion may share at least some common molecular mecha- min, 4C), the supernatant (S) and pellet (P) fractions were mixed
with SDS-containing sample buffer, resolved in SDS-PAGE, andnisms.
detected by Western blotting with an anti--tubulin antibody. TheIn addition to normal physiological contexts, axonal
amount of tubulin protein in each sample was determined by com-degeneration has frequently been observed in many
paring the intensity of the bands with standard samples by NIHtypes of neurodegenerative diseases and after various
imager program. Depolymerization ratio was calculated as [S/
neuronal insults (Raff et al., 2002; Coleman and Perry, (S  P)].
2002). Such axon degeneration could occur either to-
gether with or independent of cell body apoptosis. For Optic Crushing, Fixation, and Immunohistochemistry
apoptosis-independent local axon degeneration, a typi- For optic nerve crushing, we followed the protocol described by
Meyer et al. (1994). To study the protective effect of MG132, acal example is the “dying back” process in aging Pur-
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gelfoam presoaked with PBS or 50 M MG132 was attached to the and microtubules from axonally transported actin and tubulin after
axotomy. J. Neurosci. Res. 43, 412–419.lesion site of the optic nerve for 60 min prior to crushing (mimicking
the pretreatment) and was kept in the lesion site after crushing. To Koegl, M., Hoppe, T., Schlenker, S., Ulrich, H.D., Mayer, T.U., and
assess the protective effects of MG132, fiber structures as detected Jentsch, S. (1999). A novel ubiquitination factor, E4, is involved in
by immunostaining were counted from sections at similar distances multiubiquitin chain assembly. Cell 96, 635–644.
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